Patrick Marcellin
Impact in
- Hepatology top 0.01%
- Hepatitis C virus research
- Liver Disease and Transplantation
- Hepatitis Viruses Studies and Epidemiology
- Liver Diseases and Immunity
- Epidemiology top 0.01%
- Liver Disease Diagnosis and Treatment
- Hepatitis B Virus Studies
Papers in
- Hepatology 570
- Hepatitis C virus research 546
- Liver Diseases and Immunity 32
- Hepatitis Viruses Studies and Epidemiology 32
- Liver Disease and Transplantation 32
- Epidemiology 526
- Hepatitis B Virus Studies 411
- Liver Disease Diagnosis and Treatment 387
- Co-authors
- Tarik Asselah (130 shared papers)Nathalie Boyer (101 shared papers)Victor de Lédinghen (20 shared papers)Dominique Valla (59 shared papers)Michel Beaugrand (16 shared papers)Zachary Goodman (9 shared papers)Stephanos J. Hadziyannis (28 shared papers)Marianne Ziol (13 shared papers)
- Journals
- Journal of Hepatology (209 papers)Hepatology (66 papers)Gastroenterology (42 papers)Liver International (36 papers)Journal of Viral Hepatitis (25 papers)
- Partner nations
- FranceUnited StatesGermany
In The Last Decade
Patrick Marcellin
616 papers receiving 37.6k citations
Patrick Marcellin's Hit Papers
Peers
Comparison fields: 5 of 159
- Hepatology 34.2k
- Epidemiology 34.3k
- Infectious Diseases 4.1k
- Rheumatology 2.0k
- Virology 486
Countries citing papers authored by Patrick Marcellin
This map shows the geographic impact of Patrick Marcellin's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Patrick Marcellin with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Patrick Marcellin more than expected).
Fields of papers citing papers by Patrick Marcellin
This network shows the impact of papers produced by Patrick Marcellin. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Patrick Marcellin. The network helps show where Patrick Marcellin may publish in the future.
Co-authors
The 25 scholars most cited alongside Patrick Marcellin, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 635 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | Randomised trial of interferon α2b plus ribavirin for 48 weeks or for 24 weeks versus interferon α2b plus placebo for 48 weeks for treatment of chronic infection with hepatitis C virus Hit paper breakdown → | 1998 | 1908 |
| 2 | Regression of cirrhosis during treatment with tenofovir disoproxil fumarate for chronic hepatitis B: a 5-year open-label follow-up study Hit paper breakdown → | 2012 | 1274 |
| 3 | Boceprevir for Previously Treated Chronic HCV Genotype 1 Infection Hit paper breakdown → | 2011 | 1229 |
| 4 | Noninvasive assessment of liver fibrosis by measurement of stiffness in patients with chronic hepatitis C Hit paper breakdown → | 2004 | 1150 |
| 5 | Peginterferon Alfa-2a, Lamivudine, and the Combination for HBeAg-Positive Chronic Hepatitis B Hit paper breakdown → | 2005 | 1143 |
| 6 | Adefovir Dipivoxil for the Treatment of Hepatitis B e Antigen–Positive Chronic Hepatitis B Hit paper breakdown → | 2003 | 1010 |
| 7 | Peginterferon Alfa-2a Alone, Lamivudine Alone, and the Two in Combination in Patients with HBeAg-Negative Chronic Hepatitis B Hit paper breakdown → | 2004 | 847 |
| 8 | Adefovir Dipivoxil for the Treatment of Hepatitis B e Antigen–Negative Chronic Hepatitis B Hit paper breakdown → | 2003 | 749 |
| 9 | Persistence of cccDNA during the natural history of chronic hepatitis B and decline during adefovir dipivoxil therapy1 ☆ Hit paper breakdown → | 2004 | 733 |
| 10 | Long-term Therapy With Adefovir Dipivoxil for HBeAg-Negative Chronic Hepatitis B for up to 5 Years Hit paper breakdown → | 2006 | 703 |
| 11 | Controlled Attenuation Parameter (CAP): A Novel VCTE™ Guided Ultrasonic Attenuation Measurement for the Evaluation of Hepatic Steatosis: Preliminary Study and Validation in a Cohort of Patients with Chronic Liver Disease from Various Causes Hit paper breakdown → | 2010 | 659 |
| 12 | 1997 | 445 | |
| 13 | 2006 | 434 | |
| 14 | 2009 | 420 | |
| 15 | 2007 | 417 | |
| 16 | 1995 | 414 | |
| 17 | 2005 | 407 | |
| 18 | 2006 | 403 | |
| 19 | Liver diseases: A major, neglected global public health problem requiring urgent actions and large‐scale screening Hit paper breakdown → | 2018 | 384 |
| 20 | 2008 | 369 |
About Patrick Marcellin
Patrick Marcellin is a scholar working on Hepatology, Epidemiology, Rheumatology, Infectious Diseases and Immunology, having authored 635 papers that have together received 38.8k indexed citations. Recurring topics across this work include Hepatitis C virus research (546 papers), Hepatitis B Virus Studies (411 papers), Liver Disease Diagnosis and Treatment (387 papers), Systemic Lupus Erythematosus Research (63 papers), HIV/AIDS drug development and treatment (41 papers), Liver Diseases and Immunity (32 papers), Hepatitis Viruses Studies and Epidemiology (32 papers) and Liver Disease and Transplantation (32 papers). The work is most often cited by research in Hepatology (34.2k citations), Epidemiology (34.3k citations), Infectious Diseases (4.1k citations), Rheumatology (2.0k citations) and Virology (486 citations). Patrick Marcellin has collaborated with scholars based in France, United States and Germany. Frequent co-authors include Tarik Asselah, Nathalie Boyer, Victor de Lédinghen, Dominique Valla, Michel Beaugrand, Zachary Goodman, Stephanos J. Hadziyannis, Marianne Ziol, Claude Degott and Pierre Bédossa. Their work appears in journals such as Journal of Hepatology, Hepatology, Gastroenterology, Liver International and Journal of Viral Hepatitis.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.